Boris Gorovits
Company: Pfizer
Job title: Senior Director
Bio:
Boris Gorovits is Senior Director of the Bioanalytical lab at Pfizer responsible for many aspects of the Regulated and Non-Regulated Bioanalytical support for the pan-Pfizer Biotherapeutic portfolio, also co-chairs Pfizer internal Immunogenicity Expert Working Group. Recently Boris has been actively involved in industry discussions focusing on bioanalytical support for PK and immunogenicity assessment of biotherapeutic modalities, including mAbs, bi-specific antibodies, antibody drug conjugates and gene therapy. Boris authored 50+ manuscripts and book chapters, is a frequent presenter at various conferences, is a past Chair for the AAPS BIOTEC section, past large molecule BA track lead for the AAPS PS360 2018, currently AAPS Awards committee chair.
Seminars:
Live Q&A – Ask the speakers your questions 1:30 pm
day: Day One
Recommendations for the Development of Cell-Based Anti-Viral Vector Neutralizing Antibody Assays 12:00 pm
• All humans may be exposed to natural Adeno-Associated Virus (AAV) infections resulting in an immune response against the virus prior to treatment • High prevalence of pre-existing anti-AAV immunity may be expected, leading to limitation for AAV-based gene therapy treatment • Recommendations for the development and validation of cell-based anti-AAV NAb detection methods will…Read more
day: Day One